Key points are not available for this paper at this time.
These results support further investigation of xanomeline as a novel approach to treating schizophrenia.
Shekhar et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: